Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39756844

Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2025 Jan
First author
Mina R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2025 Jan;12(1):e6-e8. doi: 10.1016/S2352-3026(24)00346-6.
    note
    Source null
    related pmid
    39756846
    relationship
    Comment in

Authors and identifiers

  1. name
    Mina R
    type
    Author
  2. name
    Mylin AK
    type
    Author
  3. name
    Yokoyama H
    type
    Author
  4. name
    Magen H
    type
    Author
  5. name
    Alsdorf W
    type
    Author
  6. name
    Minnema MC
    type
    Author
  7. name
    Shune L
    type
    Author
  8. name
    Isufi I
    type
    Author
  9. name
    Harrison SJ
    type
    Author
  10. name
    Shah UA
    type
    Author
  11. name
    Schecter JM
    type
    Author
  12. name
    Vogel M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mina R
    type
    Author
  2. name
    Mylin AK
    type
    Author
  3. name
    Yokoyama H
    type
    Author
  4. name
    Magen H
    type
    Author
  5. name
    Alsdorf W
    type
    Author
  6. name
    Minnema MC
    type
    Author
  7. name
    Shune L
    type
    Author
  8. name
    Isufi I
    type
    Author
  9. name
    Harrison SJ
    type
    Author
  10. name
    Shah UA
    type
    Author
  11. name
    Schecter JM
    type
    Author
  12. name
    Vogel M
    type
    Author
bibliography ids
  1. nci-bib-6c4d91b2258c4420ee0febd5
book metadata
content sha256
841b9fede8a5f7ae17eadff09608fe5e54c4bcc8e740734c25aad1abdddc2f2e
document type
citation
dois
  1. 10.1016/S2352-3026(24)00320-X
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:39756844
immutable id
pubmed:39756844@841b9fede8a5f7ae17eadff09608fe5e54c4bcc8e740734c25aad1abdddc2f2e
journal
abbreviation
Lancet Haematol
issn electronic
2352-3026
issn print
Source null
issue
1
name
The Lancet. Haematology
nlm unique id
101643584
pages
e45-e56
volume
12
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2025 Jan;12(1):e6-e8. doi: 10.1016/S2352-3026(24)00346-6.
    note
    Source null
    related pmid
    39756846
    relationship
    Comment in
outcomes validated
false
pmid
39756844
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
43bb5d7b5ed050d6839a1c4262ae6445c324f987efe7f618ecb81c0108721953
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2025 Jan
precision
month
year
2025
publication types
  1. Journal Article
  2. Clinical Trial, Phase III
  3. Randomized Controlled Trial
  4. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39756844/
title
Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial.

Preserved source evidence · Not medical advice